Work

P1.01-87 Osimertinib Acquired Resistance Mechanisms and Post-Progression Outcomes in Stage IV EGFR Positive Non-Small Lung Cancer

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.802

Authors: T. Patil, A. Dimou, J. Pacheco, D. Smith, D. Aisner, D. Merrick, C. Rusthoven, B. Kavanaugh, R. Miller, E. Schenk, D.R. Camidge, P. Bunn, R. Doebele

Institutions: University of Colorado Denver, University of Colorado Cancer Center, University of Colorado Anschutz

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981866098

FWCI:

Cites:

Cited by: 1

Related to: 10